መነሻ › ላንገርሃንስ ሴል ሂስቲዮሳይቶሲስ › Texas
በTexas ለላንገርሃንስ ሴል ሂስቲዮሳይቶሲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለላንገርሃንስ ሴል ሂስቲዮሳይቶሲስ የሚደረጉ 4 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በTexas ውስጥ ያሉ ከተሞች
Official study text (English)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Dell Children's Medical Center of Central Texas, Austin
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- El Paso Children's Hospital, El Paso
- እና 6 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
180 Days – 22 Years · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05828069Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib
- Cook Children's Health Care System, Fort Worth
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ7 ኤፕሪ 2026 · NCT06582745Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Children's Medical Center- UTSW, Dallas
- Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2025 · NCT04079179Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- Dell Children's Medical Center, Austin
- Cook Children's Health Care System, Fort Worth
- Texas Children's Hospital, Houston
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2025 · NCT02670707ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።